Eminent Services Corp
Frederick, MD
- UEI
- C4PUY1BKHP59
- CAGE
- 313T8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Primary
- 325412 Pharmaceutical Preparation Manufacturing
- 484230 Specialized Freight (except Used Goods) Trucking, Long-Distance
- 493120 Refrigerated Warehousing and Storage
- 493190 Other Warehousing and Storage
- 541380 Testing Laboratories and Services
- 541511 Custom Computer Programming Services
- 541512 Computer Systems Design Services
- SAM.gov registration date
- Physical address
- 7495 New Technology Way, Frederick, MD 21703, USA
- Website
- emiserv.com
- Founded
- 1997
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nhgri: service: refrigerated storage of investigational drug: severable | Office of Logisitics and Acquisition Operations | $29,106 | |
| Niaid clinical products center (CPC) | National Institute of Allergy and Infectious Diseases | $3,634,911 | |
| Refrigerated transport and storage of investigational drug - new award | National Heart Lung and Blood Institute | $29,276 | |
| Services for package and delivery of mannac. POP: 06/15/2024 - 09/30/2024 | National Human Genome Research Institute | $14,626 | |
| Niaid division of allergy, immunology & transplantation: immune mediated diseases clinical products center (CPC) | National Institute of Allergy and Infectious Diseases | $19,798,741 |
About Eminent Services Corp
Eminent Services Corp, a minority-owned, Subcontinent Asian American-owned for-profit manufacturer and service provider based in Frederick, Maryland, delivers pharmaceutical oversight, cold-chain logistics, and clinical trial support services to the National Institutes of Health and its institutes as a prime contractor on a $32.9 million NIH contract and as a sub-recipient on NIH-funded research grants. The vendor competes on a non-set-aside basis across its prime federal footprint and operates with 57% of recent awards as prime (8 awards) and 43% as sub-recipient (6 awards).
Eminent's customer base is wholly concentrated within the Department of Health and Human Services National Institutes of Health, accounting for 100% of recent awards across five distinct NIH institutes and offices. The National Institute of Allergy and Infectious Diseases anchors the largest dollar exposure at $62.2 million across four awards, followed by the NIH Office of Logistics and Acquisition Operations with a single $45 million potential-value award. The National Human Genome Research Institute has placed three smaller awards totaling $73 thousand, and the National Institute of Diabetes and Digestive and Kidney Diseases has five awards of undisclosed value. Eminent's prime contract portfolio centers on a $32.9 million definitive cost-plus-fixed-fee contract with NIAID awarded April 1, 2026, running through March 31, 2033 with six optional annual extensions, covering pharmacy and pharmaceutical oversight of NIAID and NIH-funded clinical trials, including study product management, regulatory document maintenance, and Drug Master File co-submissions. The contract is structured as a level-of-effort engagement with a base of approximately ten full-time equivalents per year, with options for increased effort up to five times per contract year, and represents a follow-on to a prior pharmacy support contract awarded in fiscal 2019. Secondary prime work includes a $29,276 firm fixed-price purchase order with NHGRI (awarded September 3, 2025, completing August 31, 2026) for refrigerated transport and storage of investigational drugs and a $29,106 sole-source purchase order with NHGRI (awarded September 1, 2026, completing August 31, 2027) for refrigerated storage of clinical-grade investigational drug in powder-in-sachet format, where Eminent maintains FDA-reporting documentation familiarity and in-house FDA-required drug-labeling capability.
Across federal grant sub-awards, Eminent serves as a sub-recipient under the University of South Florida on four awards supporting the Data Coordinating Center for Type 1 Diabetes TrialNet (funded by NIDDK, awarded December 2, 2025, February 7, 2025, April 29, 2024, and another in June 2025 supporting a Phase 2A clinical trial of JAK inhibitors). Eminent also subcontracts to Rho Federal Systems Division on a May 1, 2023 NIAID-funded grant sub-award for biorepository storage and sample distribution services.
Recent activity shows growth from two awards in 2019 to four in 2025 and three in 2026. SCI-reported invoicing across prime service contracts ran $10.5 million from FY2022 through FY2024 (FY2022: $2.9 million with 8.1 FTEs; FY2023: $4.1 million with 9.9 FTEs; FY2024: $3.5 million with 9.9 FTEs), with government-paid hourly rates for prime contract labor at a median of approximately $170/hour, ranging from about $169/hour at the tenth percentile to $194/hour at the ninety-ninth percentile. The vendor performs substantially all work in-house; SCI data shows zero sub-hours across prime contracts. Recompete exposure in the next twenty-four months is minimal at $58 thousand combined value, though the $32.9 million NIAID contract's base period completes March 31, 2027, triggering option-period decisions within that window.
Contract vehicles
Quick answers
What is Eminent Services Corp's UEI?
Eminent Services Corp's Unique Entity ID (UEI) in SAM.gov is C4PUY1BKHP59.
What is Eminent Services Corp's CAGE code?
Eminent Services Corp's CAGE code is 313T8.
What is Eminent Services Corp's primary NAICS code?
Eminent Services Corp's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Eminent Services Corp located?
Eminent Services Corp's physical address in SAM.gov is 7495 New Technology Way, Frederick, MD 21703, USA.
Is Eminent Services Corp registered in SAM.gov?
Yes. Eminent Services Corp's SAM.gov registration is active through January 22, 2027.
Which contract vehicles does Eminent Services Corp hold?
Eminent Services Corp holds a place on 1 federal contract vehicle: Drug Formulation and Manufacturing Contracts 2019.
What is Eminent Services Corp's most recent federal award?
Eminent Services Corp's most recent federal contract award is Nhgri: service: refrigerated storage of investigational drug: severable (75N98026P01011), from Office of Logisitics and Acquisition Operations, on September 1, 2026.
On GovTribe
See Eminent Services Corp's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors